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Objectives: Walking impairments are common in individuals with multiple sclerosis.
Trunk control is a prerequisite for walking; however, knowledge regarding whether
core stability and balance training influence walking is limited. This study aimed to
investigate the immediate and long‐term effects of a group‐based, individualized,
comprehensive core stability and balance intervention (GroupCoreDIST) compared
with those of standard care on walking.
Methods: This assessor‐blinded, prospective randomized controlled trial included
80 participants (Expanded Disability Status Scale scores 1–6.5) randomly allocated
to GroupCoreDIST, conducted in groups of three for 60 min three times per week
for 6 weeks (18 sessions) or standard care (n = 40/40). One participant attended no
posttests, leaving 79 subjects for intention‐to‐treat analysis. The assessments were
performed at baseline and at Weeks 7, 18, and 30. Outcomes included the 2‐min walk
test (2MWT), 10‐m walk test‐preferred/fast/slow speed (10MWT), Multiple Sclerosis
Walking Scale‐12 (MSWS‐12), Patient Global Impression of Change‐walking (PGIC‐
walking), Rivermead Visual Gait Assessment (RVGA), and ActiGraphsWgt3X‐BT
activity monitors (ActiGraph). The statistical analyses included repeated‐measures
mixed models performed in IBM SPSS Version 24.
Results: There were no significant between‐group differences in the outcome mea-
surements at baseline. The mean differences between groups were significant at all
follow‐up time points in favour of GroupCoreDIST for the 2MWT, 16.7 m at 7 weeks
(95% CI [8.15, 25.25], 15.08 m at 18 weeks (95% CI [6.39, 23.77]) and 16.38 m at
30 weeks (95% CI [7.65, 25.12]; and the PGIC‐walking, 0.89 points at 7 weeks
(95% CI [1.34, 0.45]), 0.97 points at 18 weeks (95% CI [1.42, 0.52]), and 0.93 points
at 30 weeks (95% CI [1.39, 0.48]; all p ≤ .001). The 10MWT‐fast speed and the
MSWS‐12 showed significant between‐group differences at 7 and 18 weeks and- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any
d, the use is non‐commercial and no modifications or adaptations are made.
rnational Published by John Wiley & Sons Ltd
wileyonlinelibrary.com/journal/pri 1 of 14
2 of 14 ARNTZEN ET AL.the RVGA at 7 weeks. No between‐group differences were found regarding activity
level (ActiGraph) or the 10MWT‐preferred or slow speed.
Conclusion: Compared with standard care, GroupCoreDIST significantly improved
walking immediately after the intervention for up to 24 weeks of follow‐up.
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Multiple sclerosis (MS) is a chronic, demyelinating disease in the central
nervous system that may lead to varied impairments, such as somato-
sensory deficits, paresis, coordination difficulties, and visual problems.
These impairments may lead to walking problems (Freund, Stetts, &
Vallabhajosula, 2016), which are common during both the early and
later stages of the disease (Comber, Galvin, & Coote, 2017;
Langeskov‐Christensen et al., 2017). Trunk control, also termed core
stability, is imperative for monitoring displacements and optimizing
steps while walking (Huisinga, St George, Spain, Overs, & Horak,
2014). Trunk control is accomplished through anticipatory postural
adjustments (APAs) and compensatory postural adjustments (CPAs;
Krishnan, Kanekar, & Aruin, 2012a, 2012b). Optimal trunk control relies
on adequate somatosensory, motor, and musculoskeletal systems,
which are frequently compromised in the MS population (Cameron &
Lord, 2010). Reduced postural control, impaired core muscle activation,
less effective APAs, and increased reliance on CPAs have been reported
in individuals withMS (Krishnan et al., 2012a, 2012b). Inexpedient com-
pensatorymovement patterns develop over time (Francis & Song, 2011)
and may interfere with trunk control due to the inefficient activation of
core muscles; for instance, a malalignment in the ankles, knees, and hips
may result in the increased use of hip strategy. Coremuscle activation is
considered important for quality of movementwhile walking (Gjelsvik &
Syre, 2016; Kalron & Givon, 2016), and impairments in this area may
lead to fewer and shorter steps (Sosnoff, Sandroff, & Motl, 2012), a
reduced walking speed (Cameron & Lord, 2010), increased risk of falls,
and restricted activities of daily living (Nilsagard, Denison, Gunnarsson,
& Bostrom, 2009) and may increase cognitive attention toward walking
(Wajda & Sosnoff, 2015).
Only a few studies examined the effects of core stability interven-
tions on walking in individuals with MS. Three randomized controlled
trials (RCTs) compared Pilates exercises and standardized physical
therapy (Expanded Disability Status Scale [EDSS] < 7). Two of them
demonstrated significant within‐group improvements in walking; how-
ever, no between‐group differences were observed (Duff et al., 2018;
Kalron, Rosenblum, Frid, & Achiron, 2017). The third RCT observed
differences between standardized exercises and relaxation; however,
no differences were observed between Pilates and the mentioned
interventions (Fox, Hough, Creanor, Gear, & Freeman, 2016). A con-
trolled trial (EDSS 0–4) comparing Pilates with home‐based exercises
indicated significant within‐group effects on walking (Guclu‐Gunduz,Citaker, Irkec, Nazliel, & Batur‐Caglayan, 2014), and two smaller stud-
ies (EDSS 3–6.5) demonstrated short‐term improvements in walking
parameters after Pilates (Freeman et al., 2010; Freeman & Allison,
2004). In contrast to the current study, none of these studies demon-
strated between‐group differences, described a physical therapy
examination, or presented how the individualization of the exercises
was conducted. In the above‐mentioned studies, Pilates exercises
were considered the voluntary activation of deep abdominal muscles
(Fox et al., 2016). Traditionally, Pilates also includes cognitive atten-
tion, posture control, movement, precision, flow during transition,
and coordinated breathing (Wells, Kolt, & Bialocerkowski, 2012). Only
one study presented group training, only two included participants
with low EDSS scores (1–2.5), and in all studies, the follow‐up periods
were absent or short. In general, exercise therapy is associated with
improvements in walking; however, no interventions have been shown
to be more effective than others in individuals with MS (Hogan &
Coote, 2013; Snook & Motl, 2009), and some have demonstrated lim-
ited valuable impacts (Motl et al., 2017).
Studies investigating walking using a long‐term follow‐up are
called for (Snook & Motl, 2009), as are group‐based interventions,
because group settings are considered economically efficient
(Humphreys, Drummond, Phillips, & Lincoln, 2013). Studies examining
individualized interventions interlinking core stability, dual tasks, and
somatosensory retraining have been recommended (Fox et al., 2016;
Gunn, Markevics, Haas, Marsden, & Freeman, 2015).
A new group‐based, individualized, comprehensive, core stability,
and balance intervention called GroupCoreDIST (D = dual task, dose;
S = somatosensory, stability, selective movement; I = individualized,
insights; T = training, teaching) has been developed (Normann,
Zanaboni, Arntzen, & Øberg, 2016). The feasibility of GroupCoreDIST
was demonstrated in a qualitative observation study (Dybesland &
Normann, 2018) and a feasibility pilot study that showed significant
within‐group effects on balance and walking in 12 individuals with
MS (EDSS 1–6.5; Normann, Salvesen, & Arntzen, 2016). In the current
study, GroupCoreDIST was compared with standard care in an RCT.
The results from the two primary and one secondary outcomes
regarding trunk control and balance have already been published,
demonstrating short‐ and long‐term significant between‐group effects
on the Trunk Impairment Scale‐Norwegian Version and the Mini Bal-
ance Evaulation Systems Test (Mini‐BESTest) (p < .05; both primary
outcomes) and the Patient Global Impression of Change‐balance
(p < .05; secondary outcome; Arntzen et al., 2019). The
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and addresses the following research question: What are the immedi-
ate and long‐term effects of GroupCoreDIST compared with standard
care on walking in individuals with MS?2 | METHODS
2.1 | Design
This two‐armed, prospective, single‐blinded RCT included 80 ambulant
individuals with MS. The study protocol was registered at ClinicalTrials.
gov, and the protocol article has been previously published elsewhere
(Normann, Zanaboni, et al., 2016). This study was approved by the
Regional Committees for Medical and Health Research Ethics in
Norway and complied with the Declaration of Helsinki.2.2 | Subjects and study setting
In August 2015, letters of invitation with a consent form were sent by
the MS nurse at the Department of Neurology, Nordland Hospital
Trust, Bodø, Norway, to 160 individuals with MS who were registered
at the MS outpatient clinic and lived in one of the six municipalities
included in the study. These municipalities were selected because they
were located in both rural and urban areas (1,200–51,000 inhabitants)
and had neurological physical therapists who were interested in learn-
ing GroupCoreDIST. A reminder letter was subsequently sent to
ensure maximum patient enrolment. Ninety‐three individuals replied
with a signed consent form. Of the 67 individuals who did not
respond, 57% had EDSS values ranging from 0 to 3.5, 21% had EDSS
values ranging from 4 to 7, and 22% had unknown EDSS values. Enrol-
ment was initiated in September 2015, and the follow‐up assessments
were completed in September 2016.
At enrolment, all participants underwent a clinical examination by a
neurologist (F. O.) to assess their EDSS and medical history, including
the type of MS, age, gender, weight, height, and medications. The
inclusion criteria were as follows: (a) a diagnosis of MS in accordance
with the McDonald criteria (Polman et al., 2011); (b) registered at
the MS outpatient clinic; (c) living in one of the six selected municipal-
ities; (d) aged 18 years or older; (e) capable of providing signed written
informed consent; and (f) an EDSS value between 1 and 6.5 (1 = minor
disability and 6.5 = able to walk 20 m with or without a walking aid). The
exclusion criteria were as follows: (a) pregnancy at the time of exami-
nation; (b) exacerbation within 2 weeks prior to enrolment; and (c)
other acute conditions resulting in compromised balance (such as
acute neurological conditions, including stroke). Of the 93 individuals
who consented to participate, 13 individuals were excluded, as fol-
lows: Two individuals did not attend the baseline assessment, five
individuals could not commit the time, three individuals had an EDSS
value of 0, one individual was pregnant, one individual was
waiting for heart surgery, and one individual had moved from the
catchment area.2.3 | Randomization
The remaining 80 individuals completed the baseline testing and were
randomly allocated to the GroupCoreDIST or standard care group by
electronic concealed randomization using a web‐based system devel-
oped and administered by the Unit of Applied Clinical Research, Insti-
tute of Cancer Research and Molecular Medicine, Norwegian
University of Science and Technology, Trondheim, Norway (www.
webcrf.medisin.ntnu.no). The system was stratified on the basis of
EDSS values of 1–3.5 and 4–6.5 to ensure a mix of individuals with
high and low EDSS values in both groups.2.4 | Preparation, procedures, and interventions
Six physical therapists conducted GroupCoreDIST after undergoing
5 days of practical and theoretical training. The therapists received a
manual containing photos and descriptions of the exercises and regis-
tered the exercises that were conducted during the group sessions to
ensure standardization of the intervention. These physical therapists
were not involved in the treatment of the standard care group.
The participants in GroupCoreDIST were divided into 13 training
groups according to municipality by the researchers B. N. and E. C. A.
The intervention was initiated with an individual clinical examination
conducted by the physical therapist. The examination included the
patient history, observations, movement analysis, and hands‐on inter-
actions. The patients' resources, movement constraints, and display
of immediate improvements in performance related to trunk control
and balance were considered. A movement analysis of posture and
activities was performed to explore balance, alignment throughout
the body, adaptation to the base of support, and interaction with the
environment in various positions. The ability to perform selective
movement (to move one part of the body while stabilizing the other
parts) to achieve coordination was considered with a specific focus
on the trunk in relation to the other parts of the body and functional
movement. The following specific assessments were performed: mus-
cle length, muscle activation and strength, tonus, somatosensory func-
tion, pain, and reflexes. On the basis of the patient's symptoms,
resources, and limitations, the physical therapist formed hypotheses
regarding the main underlying problems related to trunk control and
balance.
The group sessions were conducted in groups of three and were
led by the physical therapist for 60 min, three times per week for
6 weeks. GroupCoreDIST contains 33 exercises, and each exercise
has five optional variations to allow for individualization as the group
members concurrently conduct the same exercise (although at differ-
ent levels of difficulty). All exercises were performed barefoot and
addressed dynamic core stability defined as the coordinated activation
of local and global muscles of the trunk, pelvis, and shoulder girdle and
the muscles attached to these areas (Kibler, Press, & Sciascia, 2006).
These areas provide the coordination and stability required for selec-
tive movement in proximal body regions and the potential for selec-
tive movement in the upper and lower limbs (Kibler et al., 2006). The
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according to the participants' symptoms. All exercises addressed core
muscle activation; however, the focus in the exercises was on the task,
in order to use less cognitive attention directed toward the core. For
instance, the participants were instructed to “keep your back in contact
with the therapy ball and roll the ball from side to side.” The potential
for improved core muscle activation was also obtained indirectly during
optimal alignment and adjustment to the base of support. These are
aspects that differ the GroupCoreDIST from for instance, Pilates and
general exercises. The exercises were divided into the following six
categories, which were represented in each group session: (a) somato-
sensory activation of the hands or feet by rolling a spiky ball; (b) muscle
length (enhancing concentric and eccentric activity in the muscles of
the neck and upper and lower limbs); (c) selective movement and coor-
dination (keeping one part of the body stable while moving another); (d)
training larger muscle groups in a standing position; (e) advanced chal-
lenges related to balance and postural control, such as jumping; and
(f) relaxation (systematically performing contraction–relaxation of parts
of the body) Normann, Zanaboni, et al., 2016. Motor–motor dual tasks
were performed in all exercises as the activation of the core muscles
was coordinated with other motor tasks. The motor–cognitive dual
tasks included singing, rhyming, or calculating while performing exer-
cises with the additional goal of promoting group dynamics and engage-
ment. Verbal instructions and hands‐on facilitation were allowed to
improve the movement quality, decrease inexpedient compensatory
movement patterns, and optimize the movement experience
(Normann, 2018; Vaughan‐Graham & Cott, 2016). The protocol article
provides details and further examples of the exercises (Normann,
Zanaboni, et al., 2016). All group members received a booklet with
illustrations of the exercises, and the physical therapist prescribed
unsupervised home‐based exercises to be conducted twice per week
for 30 min. The participants were encouraged to continue performing
the home‐based exercises after the intervention was completed for
30 min twice per week; however, these exercises were voluntary and
unsupervised. The participants in GroupCoreDIST were encouraged
to not seek other physical therapy during the 6‐week intervention.
The control group continued their regular routines, and the partic-
ipants were encouraged to maintain their current level of physical
activity. The participants were informed that they could see a physical
therapist and seek any health care as required. Physical therapy was
free to individuals with MS in Norway (at the time the study was con-
ducted) and offered by both generalists and specialists; most often,
physical therapy is received in a private practice or community‐based
service. The self‐reports from the standard care group showed that 30
individuals (75%) did not visit a physical therapist within the 6 weeks
of intervention/standard care, five individuals (12.5%) visited a physi-
cal therapist once per week, four individuals (7.5%) visited a physical
therapist two to three times per week, and one individual visited a
personal trainer. The contents of the sessions included strength train-
ing (10 individuals), endurance training (eight individuals), Pilates (two
individuals), and yoga (one individual). The trainings were unsuper-
vised for four individuals and tailored by the physical therapist for five
individuals. The participants in both standard care andGroupCoreDIST groups were encouraged to continue their usual med-
ical treatment.2.5 | Outcome measurements and procedure
The assessments were conducted at baseline, after the intervention
was completed (Week 7; primary end‐point), and at Weeks 18 and
30. Walking aids were allowed, and the participants were encouraged
to use the same walking aid and shoes during all assessments. Two
assessors who were blinded to the group allocation and adequately
trained in the standardized test procedures conducted the
assessments.
The outcome measures of walking included the 2‐min walk test
(2MWT), 10‐m walk test (10MWT), Multiple Sclerosis Walking Scale‐
12 (MSWS‐12), Patient Global Impression of Change‐walking (PGIC‐
walking), the Rivermead Visual Gait Assessment (RVGA), and
ActiGraphsWgt3X‐BT monitors (ActiGraph). The 2MWT measures
walking distance, has good reliability and validity (Rossier & Wade,
2001), and is recommended for intervention studies (Gijbels et al.,
2012). The participants were instructed to walk as far as they could
in a 22‐m‐long hallway and turn at the end of the hall for a period
of 2 min. The 10MWT measures walking speed and was conducted
with a standing start at (a) the preferred speed, (b) slow speed, and
(c) fast speed. The assessment has good reliability and validity among
individuals with MS (Paltamaa, West, Sarasoja, Wikstrom, & Malkia,
2005; Rossier & Wade, 2001).
The MSWS‐12 captures how participants perceive their limitations
while walking as a result of MS over the previous 2 weeks. Each of the
12 items is scored from 1 to 5 (lowest score 12 = no limitation). The
MSWS‐12 has good reliability and validity among individuals with
MS (Hobart, Riazi, Lamping, Fitzpatrick, & Thompson, 2003; Kieseier
& Pozzilli, 2012). The total score was transformed into a 0–100 scale
as recommended (Baert et al., 2014). The PGIC‐walking is scored on
a 7‐point Likert scale and measures how the participants perceive
changes in walking (1 = very much worse, 4 = no change, and 7 = very
much improved) compared with walking before the 6 weeks of
GroupCoreDIST or standard care (Farrar, Young, LaMoreaux, Werth,
& Poole, 2001).
RVGA is a reliable and valid quantitative measure of an individual's
gait quality (Lord, Halligan, & Wade, 1998). RVGA describes how the
gait pattern varies from normal and is measured on a 4‐point scale
(0 = normal and 4 = great abnormality) with a total score ranging from
0 to 59 when conducting two observations of the arms and 18 obser-
vations of the trunk and lower extremities (Lord et al., 1998). The par-
ticipants were videotaped while walking and scored on the basis of
the film.
The ActiGraph is an activity monitor that registers information
regarding the participants' activity level: number of steps and duration
of intensity in activity (divided into different intensity levels: inactive,
low, moderate, and vigorous; Block et al., 2016). The monitor was
worn in a belt around the participants' waist for 7 days after each
assessment time point. The ActiGraph has been found to be an
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individuals with MS (Weikert, Motl, Suh, McAuley, & Wynn, 2010).
General physical activity, the number of physical therapy treat-
ments, perturbations, changes in medications and general well‐being
were recorded for both groups during the 6 weeks of GroupCoreDIST
or standard care, and the number of home exercise sessions was addi-
tionally obtained for the GroupCoreDIST group.2.6 | Sample size
The sample size calculation was based on assumptions of change in
the Mini‐BESTest, where a 0.75 standard deviation (SD) between the
intervention group and the control group was considered relevant.
The results of the Mini‐BESTest are presented in another manuscript
(Arntzen et al., 2019). To achieve an 80% chance of detecting a
0.75 SD difference between the groups at a significance level of .05
(α), 28 individuals with MS were required per group. Anticipating a
30% dropout rate, we aimed to recruit at least 72 participants.2.7 | Statistical analysis
Descriptive statistics (frequency, descriptive, and explore) were used
to describe the demographic and clinical variables. The between‐group
differences over time were calculated using repeated‐measures mixed
models in IBM SPSS Version 24. The mixed‐model approach has an
advantage in addressing missing values and provides many options
for adjusting for the dependence between repeated measures. An
intention‐to‐treat analysis was performed for all participants with
postassessment scores; however, some participants had missing
observations. In the repeated‐measures mixed‐model analyses, the
data structure involved four repeated measurements coded as a
numeric time variable, and each follow‐up time point was used as a
reference. We adjusted for baseline by maintaining the baseline vari-
able as a covariate in the model as recommended in the litterature
(Twisk, 2013; Vickers & Altman, 2001). The final model of all out-
comes included all independent variables that reached significance at
p = .05 in any model. Group, time point, EDSS, gender, type of MS,
age, and an interaction term composed of the time and group variables
were included in the model. Other interaction terms with the interven-
tion indicator were evaluated; however, these interaction terms did
not reach significance and, thus, were not included. The estimated
marginal means were used to create plots illustrating the effects of
the intervention over time.3 | RESULTS
The 80 participants were randomly allocated to the GroupCoreDIST
(n = 40) or the standard care (n = 40) group after the baseline testing
(Figure 1). One participant in the intervention group dropped out
before the postassessments and was excluded from the study. Thus,
79 individuals were included in the intention‐to‐treat analysis. At the
18‐week assessment, one individual from the control group was lostto follow‐up due to illness, and three individuals from the control
group missed the assessments. At the 30‐week assessment, two addi-
tional individuals from each group missed the assessments. The demo-
graphic and clinical characteristics are shown in Table 1.
The self‐reported data collected during the 6 weeks of
GroupCoreDIST/standard care demonstrated that the group sessions
were attended with a mean of 2.5 sessions (SD 0.16) per individual per
week. In the standard care group, five individuals reported receiving indi-
vidually adjusted physical therapy, whereas four individuals conducted
unsupervised training at the physical therapist's gym (an average of
0.28 physical therapy sessions, SD 0.85, for the whole group during
the 6 weeks). There was no significant between‐group difference in gen-
eral physical activity during the 6 weeks; the mean difference was 4.38
half‐hours during the entire period (95% CI [19.75, 10.98]; p = .57). Both
groups recorded a mean general well‐being of 2.48 of 5 points (SD 0.90).
One individual reported a sensory relapse, which was verified by a neu-
rologist, during the first week of the intervention. No injuries occurring
as a result of the intervention were reported. The control group reported
no new relapses. The medications remained unchanged. During the
6 weeks of the intervention, the GroupCoreDIST group reported a mean
of 2.14 home‐based exercise sessions (SD 1.19). Thirty‐eight of the 40
participants in the GroupCoreDIST group reported that they continued
to perform home‐based GroupCoreDIST exercises at Week 18, and
two individuals reported the same at Week 30.
The primary outcomes of this study, that is, the Trunk Impairment
Scale‐Norwegian Version and the Mini‐BESTest, have already been
reported in a different paper, which demonstrated statistically signifi-
cant between‐group differences at 7, 18, and 30 weeks (p < .05) and
overall significant effects by group (p < .05; Arntzen et al., 2019).
The results of the mixed‐model analyses of the secondary out-
comes are presented inTable 2. These results demonstrate statistically
significant between‐group differences in favour of GroupCoreDIST at
all follow‐up time points for the 2MWT and the PGIC; between‐group
differences at 7 and 18 weeks for the 10MWT‐fast and the MSWS‐
12; and at 7 weeks for the RVGA.
At baseline, the GroupCoreDIST and standard care group demon-
strated a mean walking distance on the 2MWT of 165.18 m (95% CI
[149.74, 180.62] and 170.56 m (95% CI [157.61, 183.51]), respec-
tively. The 2MWT (Figure 2) demonstrated an overall group effect
(p < .00), and all posttests demonstrated a significant between‐group
difference (p < .001). The 10MWT‐fast speed (Figure 3) demonstrated
an overall significant difference by group (p = .016) and significant
between‐group effects at 7 (p = .011) and 18 weeks (p = .04). No sig-
nificant differences were identified in the 10MWT‐slow or 10MWT‐
preferred speeds or activity (neither number of steps nor activity level)
at any time point. The RVGA demonstrated a significant between‐
group difference at 7 weeks (p = .03).
The MSWS‐12 100scale (Figure 4) demonstrated an overall signif-
icant difference by group (p = .011) and significant between‐group dif-
ferences at 7 (p = .004) and 18 weeks (p = .019). The PGIC‐walking
(Figure 5) demonstrated an overall significant difference by group
(p < .00) and significant between‐group differences at all time points
(p < .00).
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This assessor‐blinded prospective RCT evaluated the short‐ and
long‐term effects of a 6‐week GroupCoreDIST intervention compared
with standard care. The results demonstrated significant between‐
group effects in favour of GroupCoreDIST on walking distance and
self‐perceived change in walking that lasted for 24 weeks, on fast
walking speed and self‐perceived walking mobility that lasted for
12 weeks, and on gait quality immediately after the intervention
was completed.FIGURE 1 Flowchart of the recruitment, allocation and retention of part4.1 | Strengths and weaknesses compared with
those of other studies
Several studies have shown that core control is important for balance
(Aruin, Kanekar, & Lee, 2015; Borghuis, Hof, & Lemmink, 2008; Kibler
et al., 2006). However, knowledge regarding whether comprehensive
core stability and balance training impact walking is limited. In the cur-
rent study, the participants were mildly impaired given their low EDSS
scores (average 2.36). Despite the low overall disability indicated by
the EDSS, the participants had substantial walking limitationsicipants throughout the study. MS, multiple sclerosis
TABLE 1 Baseline demographic and clinical characteristics of the
standard care and GroupCoreDIST groups as measured by means,







Age 48 (8.75) [31–67] 52.2 (12.9) [24–77]
Height (cm) 171.8 (9.06) [155–191] 169.26 (7.67) [154–185]
Weight (kg) 77.7 (14.15) [53–116] 71.7 (12.16) [44–99.8]
Gender
Women 29 (72.5%) 27 (69.2%)
Men 11 (27.5%) 12 (30.8%)
Smoker
No 30 (75%) 36 (92.3%)




36 (90%) 32 (82.1%)
Primary
progressive
2 (5%) 5 (12.8%)
Secondary
progressive
2 (5%) 2 (5.1%)
EDSS 2.28 (1.28) [1–5.5] 2.45 (1.65) [1–6.5]
Age at diagnosis 37.4 (10.06) [21–64] 41.9 (10.26) [19–63]
Years since
diagnosis
10.68 (7.27) [1–28] 10.04 (7.85) [0.5–33]




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































ARNTZEN ET AL. 7 of 14considering their average walking distance at baseline (167.87 m in the
2MWT), which was significantly shorter than the previously published
average distance in healthy individuals (211 m; 95% CI [191, 234 m];
Selman, de Camargo, Santos, Lanza, & Dal Corso, 2014). This finding
suggests the need for early rehabilitation in mildly impaired individuals
to improve walking, which is also indicated in other studies
(Langeskov‐Christensen et al., 2017). A clinically meaningful change
in the 2MWT was defined as an improvement of 9.6 and 6.8 m from
the patient and clinician perspectives, respectively, in one study (Baert
et al., 2014) and a 12% improvement in another study (Learmonth,
Dlugonski, Pilutti, Sandroff, & Motl, 2013). Our results demonstrated
a clinically meaningful change in the GroupCoreDIST group at all
assessment points as follows: 18‐m (11%) improvement at 7 weeks,
20‐m (12%) improvement at 18 weeks, and 18‐m (11%) improvement
at 30 weeks. The 10MWT‐fast speed also showed significant effects
at 7 and 18 weeks. However, walking at the preferred or a slow speed
did not improve, which may be related to the psychometrics of the
test as walking at the preferred speed exhibited more within‐day var-
iability than walking at a fast speed (Feys et al., 2014). The 10MWT‐
fast speed is more comparable with long walking tests than walking
at the preferred speed, and the 2MWT is more comparable with habit-
ual walking behaviour than the 10MWT (Gijbels et al., 2010).
In contrast to the clinical walking outcomes, the activity monitors
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FIGURE 2 Mean and 95% CI of the 2‐min
walk test in the GroupCoreDIST and standard
care groups at baseline and Weeks 7, 18, and
30
FIGURE 3 Mean and 95% CI of the 10‐m
walk test‐fast speed in the GroupCoreDIST
and standard care groups at baseline and
Weeks 7, 18, and 30
ARNTZEN ET AL. 9 of 14GroupCoreDIST did not emphasize activity or encourage the partici-
pants to increase their activity level. Compared with healthy individ-
uals in Norway, our participants had lower activity levels (Hansen
et al., 2019); however, compared with individuals with MS, partici-
pants in both groups had higher amount of steps per day than
reported in a prior study (Learmonth & Motl, 2016). This may be
explained due to the high amount of individuals with EDSS 1–2 in
our study and the wide standard deviations in both groups, implying
a great variation regarding activity.
The MSWS‐12 demonstrated significant effects at 7 and 18 weeks.
There is no clear agreement regarding the definition of a standard clin-
ically meaningful change in the MSWS‐12; however, values between
−6 and −11 points have been suggested previously (Baert et al.,
2014; Baert et al., 2018; Hobart et al., 2003; Mehta et al., 2015).The current study demonstrated a −7‐point improvement in the
GroupCoreDIST group from baseline to 7 weeks, indicating a clinically
meaningful improvement. The MSWS‐12 is associated with changes in
walking distance and speed (Pilutti et al., 2013), which were observed
in this RCT. The MSWS‐12 has also been suggested to particularly
capture changes in individuals within the low EDSS range
(Langeskov‐Christensen et al., 2017), which was the case for most par-
ticipants. The MSWS‐12 and the PGIC‐walking reflect improvements
in assessed walking distance and speed. The RVGA demonstrated that
the participants had few abnormalities in the quality of walking or at
least abnormalities that were captured by this outcome measurement.
The low baseline scores in both groups may indicate a borderline floor
effect and, thereby, limited the possibilities for improvement in the
RVGA because the creators of this outcome measurement indicated
FIGURE 4 Mean and 95% CI of the Multiple Sclerosis Walking
Scale‐12 100 scale in the GroupCoreDIST and standard care groups
at baseline and Weeks 7, 18, and 30
10 of 14 ARNTZEN ET AL.that an 11‐point change is a significant change in gait quality (Lord
et al., 1998).
The results from this study contradict the view that gait training is
required for improving walking (Lederman, 2010) because
GroupCoreDIST does not include walking. Other studies assessing
walking after Pilates, resistance training, or general exercises have
demonstrated effects on walking speed (Freeman et al., 2010; Kalron
et al., 2017; Kjølhede, Vissing, & Dalgas, 2012; Pearson, Dieberg, &
Smart, 2015) or distance (Freeman & Allison, 2004; Gunn et al.,
2015; Kalron et al., 2017; Kjølhede et al., 2012; Pearson et al., 2015);
however, some studies have shown no effect on walking (Fox et al.,
2016; Kjølhede et al., 2012). The current study is distinguished by
the finding that the walking distance, speed, quality, and self‐perceived
outcome measures of walking all improved, which may indicate that
exercises that comprehensively address aspects of core stability and
the prerequisites of optimal balance control influence walking.4.2 | Explanation of findings
GroupCoreDIST highlights trunk muscle activation in coordination with
activity in the limbs and other underlying aspects of balance, such as
somatosensory activation of the feet, adaptation to the base of support,
muscle length, and larger muscle groups. The improvements in walking
may be related to the high dose of trunk muscle activation, which is
imperative for monitoring displacements and optimizing steps while
walking (Huisinga et al., 2014). Moreover, the intervention addresses
malalignment of the trunk, hip, ankle, and foot, which are all important
elements for adequate ankle and hip strategies and the ability to make
longer steps, which may explain the faster walking speed (Gjelsvik &
Syre, 2016; Shumway‐Cook & Woollacott, 2017). Optimal somatosen-
sory information, alignment, and dynamic adaptation to the base of sup-
port were addressed in the exercises because individuals with MS‐
induced mild to moderate disability tend to have decreased sensation
in their feet (Citaker et al., 2011). Although these aspects are essential
for walking (Arpin, Gehringer, Wilson, & Kurz, 2017), they were unfor-
tunately not assessed as outcomemeasures in this study and, therefore,
need to be examined in future studies for a mechanistic understanding
of the components. Motor–motor dual tasks were important for all
exercises, which may have been an advantage as walking involves coor-
dination of both proximal and distal regions of the body. The significant
immediate and long‐term improvements in trunk control and balance
(Trunk Impairment Scale‐Norwegian Version and Mini‐BESTest;
Arntzen et al., 2019)may substantiate that comprehensive core stability
and balance exercises are important for walking. The self‐perceived
improvements may have motivated the participants to continue to per-
form home‐based exercises after the intervention was completed.
Nearly all (38/40) of the GroupCoreDIST participants reported
performing unsupervised home exercises at the 18‐week assessment,
which is remarkable andmay have provided sustainedwalking improve-
ments. At 30 weeks, only two of 40 participants reported performing
unsupervised home‐based exercises, which may have influenced the
lack of significant effects in most walking outcomes at this point. This
finding may indicate the need for intensive blocks of physical therapyFIGURE 5 Mean and 95% CI of the Patient
Global Impression of Change‐walking in the
GroupCoreDIST and standard care groups at
Weeks 7, 18, and 30
ARNTZEN ET AL. 11 of 14with a few months in between and also the need to explore other ele-
ments to support adherence.4.3 | Strengths and limitations of the trial
The group trainings were highly attended, which may have been the
result of motivation and group dynamics as social settings are often
motivating and may lead to increased general physical activities (Dodd,
Taylor, Denisenko, & Prasad, 2006). However, the self‐scorings indi-
cated equal activity levels in both groups throughout the 6 weeks.
Moreover, the well‐being similar scores in the two groups imply that
the social aspects of the intervention were unlikely to have caused
the improvements in walking. The lacking changes in activity may also
underscore that the effects on walking that occurred as a result of the
intervention and not due to increased activity level. One methodolog-
ical consideration is that the groups were not matched for volume of
physical therapy, which implies less attention and lower expectations
for improvement in the standard care group. However, standard care
is a common comparator in RCTs, and the content is well described
(Zwarenstein, Treweek, & Loudon, 2017). Because there is no gold
standard intervention for individuals with MS (Hogan & Coote,
2013), standard care may reflect what this group is offered in general,
which in this study demonstrated to be very little physiotherapy.
This RCT included a physical therapy examination as the basis for
individualization, which is important given that individuals with MS
have various impairments (Cameron & Lord, 2010). Individualization
may limit and create imprecision in an RCT because controlling for
the specific contents of the intervention may be compromised; how-
ever, the physical therapists were adequately trained in the interven-
tion, followed a detailed manual, and registered the exercises used
(Zwarenstein et al., 2008). No injuries related to the intervention were
reported, and only one individual reported an exacerbation (sensory),
indicating that GroupCoreDIST was well tolerated. Ambulant individ-
uals with all types of MS and varied EDSS scores (1–6.5) participated;
however, as a group, their EDSS level was quite low (mean 2.36). This
finding demonstrates walking impairments in individuals with low EDSS
as previously described in other studies (Sosnoff et al., 2012) and
displays the potential for improvements in this group. Among all partic-
ipants, 81% had an EDSS score of 1–3.5, which could indicate recruit-
ment bias and, thus, limit generalizability. Among those who did not
respond to the invitation to participate in the study, 57% had an EDSS
score of 0–3.5, and 22% had an unknown EDSS score, indicating that
the sample in this study is fairly similar to the MS population in the
MS outpatient clinic. We consider the outpatient clinic to be no differ-
ent from others in Norway, indicating that there was no recruitment
bias; however, other countries may have given a different sample.
Multiplicity of analyses may be a limitation because we used many
outcome measures to explore walking. However, exploring different
aspects of walking is important because GroupCoreDIST is a new inter-
vention. Additionally, physical therapists from six municipalities partici-
pated, rendering the external validity high and the results transferable to
other similar populations and settings (Zwarenstein et al., 2017).5 | IMPLICATIONS FOR PHYSICAL
THERAPY PRACTICE
The immediate and long‐term effects on walking demonstrated in this
study support the initiation of GroupCoreDIST in ambulant individuals
with MS (EDSS values 1–6.5). The usefulness of this approach among
people with more severe MS ought to be investigated further. The
prevailing principle of individualization in neurological physical therapy
(Rehabilitation in Multiple Sclerosis (RIMS), 2012, April) has previously
been questioned in group settings (Kalron et al., 2019; Plow,
Mathiowetz, & Lowe, 2009). In our studies, comprehensive and indi-
vidualized core stability and balance exercises were demonstrated to
be feasible (Normann, Salvesen, & Arntzen, 2016) and effective
regarding balance (Arntzen et al., 2019) and walking when performed
in small groups. Individualization may therefore be an important ele-
ment to implement in group‐based physical therapy. The high dose
and intensity of the GroupCoreDIST seemed important for the
improvements in walking, and the fact that the standard care follow‐
up in our area foremost contained low dose and general activities
may indicate that a more intensive and structured physical therapy
treatment is needed for this population.
In conclusion, compared with standard care, 6 weeks of
GroupCoreDIST produced immediate and long‐term significant and
clinically meaningful effects on walking. The intervention represents
an effective contribution to clinical practice. In future studies,
GroupCoreDIST needs to be compared with other types of exercise
programmes of equal dosage in order to establish any superiority
and support the theoretical underpinnings.ACKNOWLEDGEMENTS
We would like to thank all the individuals with MS who participated in
this study, the six physical therapists who conducted the group treat-
ment, and the two physical therapists who conducted the assess-
ments, as well as the administrations of the participating
municipalities. We would also like to thank the Department of Physical
Therapy of Nordland Hospital Trust and the MS nurse at the Depart-
ment of Neurology of Nordland Hospital Trust. We thank Professor of
Statistics Tom Wilsgaard, UiT, The Arctic University of Norway, for
help with the sample size calculation and statistical analyses. The
study was financed by the Northern Norway Regional Health Author-
ity (Helse Nord RHF, Project Grant 1240).CONFLICT OF INTEREST
The authors declare no conflict of interest.AUTHOR CONTRIBUTIONS
BN and ECA provided concept, idea, and research design. FO and a
blinded tester provided data collection. ECA, BS, BN, and PF provided
data analysis. ECA, BN, BS, PF, and FO provided writing. BN and ECA
provided project management. BN provided fund procurement, facili-
ties, and equipment.
12 of 14 ARNTZEN ET AL.REGISTRATION AND FUNDING SOURCE
This RCT is registered at ClinicalTrials.gov under registration identifier
NCT02522962. This study was financed by the Northern Norway
Regional Health Authority (Project Grant 1240). The trial received
approval from the Regional Committees for Medical and Health
Research Ethics in Norway (REK South‐East: 2014/1715‐7).
ORCID
Ellen Christin Arntzen https://orcid.org/0000-0001-5396-4071
REFERENCES
Arntzen, E. C., Straume, B. K., Odeh, F., Feys, P., Zanaboni, P., & Normann,
B. (2019). Group‐based individualized comprehensive core stability
intervention improves balance in persons with multiple sclerosis: A ran-
domized controlled trial. Physical Therapy. https://doi.org/10.1093/ptj/
pzz017
Arpin, D. J., Gehringer, J. E., Wilson, T. W., & Kurz, M. J. (2017). A reduced
somatosensory gating response in individuals with multiple sclerosis is
related to walking impairment. Journal of Neurophysiology, 118,
2052–2058. https://doi.org/10.1152/jn.00260.2017
Aruin, A. S., Kanekar, N., & Lee, Y. J. (2015). Anticipatory and compensa-
tory postural adjustments in individuals with multiple sclerosis in
response to external perturbations. Neuroscience Letters, 591,
182–186. https://doi.org/10.1016/j.neulet.2015.02.050
Baert, I., Freeman, J., Smedal, T., Dalgas, U., Romberg, A., Kalron, A., …
Feys, P. (2014). Responsiveness and clinically meaningful improvement,
according to disability level, of five walking measures after rehabilita-
tion in multiple sclerosis. Neurorehabilitation and Neural Repair, 28(7),
621–631. https://doi.org/10.1177/1545968314521010
Baert, I., Smedal, T., Kalron, A., Rasova, K., Heric‐Mansrud, A., Ehling, R., …
Feys, P. (2018). Responsiveness and meaningful improvement of
mobility measures following MS rehabilitation. Neurology, 91(20),
e1880–e1892. https://doi.org/10.1212/wnl.0000000000006532
Block, V. A. J., Pitsch, E., Tahir, P., Cree, B. A. C., Allen, D. D., & Gelfand, J.
M. (2016). Remote physical activity monitoring in neurological disease:
A systematic review. PLoS ONE, 11(4), e0154335. https://doi.org/
10.1371/journal.pone.0154335
Borghuis, J., Hof, A. L., & Lemmink, K. A. (2008). The importance of
sensory‐motor control in providing core stability: Implications for mea-
surement and training. Sports Medicine, 38, 893–916. https://doi.org/
10.2165/00007256‐200838110‐00002
Cameron, M. H., & Lord, S. (2010). Postural control in multiple sclerosis:
Implications for fall prevention. Current Neurology and Neuroscience
Reports, 10, 407–412. https://doi.org/10.1007/s11910‐010‐0128‐0
Citaker, S., Gunduz, A. G., Guclu, M. B., Nazliel, B., Irkec, C., & Kaya, D.
(2011). Relationship between foot sensation and standing balance in
patients with multiple sclerosis. Gait & Posture, 34, 275–278. https://
doi.org/10.1016/j.gaitpost.2011.05.015
Comber, L., Galvin, R., & Coote, S. (2017). Gait deficits in people with
multiple sclerosis: A systematic review and meta‐analysis. Gait &
Posture, 51(Supplement C), 25–35. https://doi.org/10.1016/j.
gaitpost.2016.09.026
Dodd, K. J., Taylor, N. F., Denisenko, S., & Prasad, D. (2006). A qualitative
analysis of a progressive resistance exercise programme for people
with multiple sclerosis. Disability & Rehabilitation, 28(18), 1127–1134.
https://doi.org/10.1080/09638280500531842
Duff, W. R. D., Andrushko, J. W., Renshaw, D. W., Chilibeck, P. D., Farthing,
J. P., Danielson, J., & Evans, C. D. (2018). Impact of Pilates exercise inmultiple sclerosis: A randomized controlled trial. International Journal
of MS Care, 20(2), 92–100. https://doi.org/10.7224/1537‐
2073.2017‐066
Dybesland, A., & Normann, B. (2018). Group treatment targeting core sta-
bility and balance for persons with multiple sclerosis; an observational
study. Physiotherapy, 101, e337–e339. https://doi.org/10.1080/
21679169.2018.1496473
Farrar, J. T., Young, J. P. Jr., LaMoreaux, L., Werth, J. L., & Poole, R. M.
(2001). Clinical importance of changes in chronic pain intensity mea-
sured on an 11‐point numerical pain rating scale. Pain, 94(2),
149–158. https://doi.org/10.1016/S0304‐3959(01)00349‐9
Feys, P., Bibby, B., Romberg, A., Santoyo, C., Gebara, B., de Noordhout, B.
M., … Dalgas, U. (2014). Within‐day variability on short and long
walking tests in persons with multiple sclerosis. Journal of the
Neurological Sciences, 338(1–2), 183–187. https://doi.org/10.1016/j.
jns.2014.01.001
Fox, E. E., Hough, A. D., Creanor, S., Gear, M., & Freeman, J. A. (2016).
Effects of Pilates‐based core stability training in ambulant people with
multiple sclerosis: Multicenter, assessor‐blinded, randomized con-
trolled trial. Physical Therapy, 96(8), 1170–1178. https://doi.org/
10.2522/ptj.20150166
Francis, J. T., & Song, W. (2011). Neuroplasticity of the sensorimotor cor-
tex during learning. Neural Plasticity, 310737, 1–11. https://doi.org/
10.1155/2011/310737
Freeman, J., & Allison, R. (2004). Group exercise classes in people with
multiple sclerosis: A pilot study. Physiotherapy Research International,
9(2), 104–107. https://doi.org/10.1002/pri.307
Freeman, J. A., Gear, M., Pauli, A., Cowan, P., Finnigan, C., Hunter, H., …
Thain, J. (2010). The effect of core stability training on balance and
mobility in ambulant individuals with multiple sclerosis: A multi‐
centre series of single case studies. Multiple Sclerosis, 16(11),
1377–1384. https://doi.org/10.1177/1352458510378126
Freund, J. E., Stetts, D. M., & Vallabhajosula, S. (2016). Relationships
between trunk performance, gait and postural control in persons with
multiple sclerosis. NeuroRehabilitation, 39(2), 305–317. https://doi.
org/10.3233/NRE‐161362
Gijbels, D., Alders, G., Van Hoof, E., Charlier, C., Roelants, M., Broekmans,
T., … Feys, P. (2010). Predicting habitual walking performance in
multiple sclerosis: Relevance of capacity and self‐report measures.
Multiple Sclerosis Journal, 16, 618–626. https://doi.org/10.1177/
1352458510361357
Gijbels, D., Dalgas, U., Romberg, A., de Groot, V., Bethoux, F., Vaney, C., …
Feys, P. (2012). Which walking capacity tests to use in multiple sclero-
sis? A multicentre study providing the basis for a core set. Multiple
Sclerosis, 18, 364–371. https://doi.org/10.1177/1352458511420598
Gjelsvik, B., & Syre, L. (2016). The Bobath concept in adult neurology (2nd
ed.). Beaverton: Ringgold Inc.
Guclu‐Gunduz, A., Citaker, S., Irkec, C., Nazliel, B., & Batur‐Caglayan, H. Z.
(2014). The effects of Pilates on balance, mobility and strength in
patients with multiple sclerosis. NeuroRehabilitation, 34(2), 337.
https://doi.org/10.3233/NRE‐130957
Gunn, H., Markevics, S., Haas, B., Marsden, J., & Freeman, J. (2015). Sys-
tematic review: The effectiveness of interventions to reduce falls and
improve balance in adults with multiple sclerosis. Archives of Physical
Medicine and Rehabilitation, 96, 1898–1912. https://doi.org/10.1016/
j.apmr.2015.05.018
Hansen, B. H., Kolle, E., Steene‐Johannessen, J., Dalene, K. E., Ekelund, U.,
& Anderssen, S. A. (2019). Monitoring population levels of physical
activity and sedentary time in Norway across the lifespan. Scandinavian
Journal of Medicine & Science in Sports, 29(1), 105–112. https://doi.org/
10.1111/sms.13314
ARNTZEN ET AL. 13 of 14Hobart, J. C., Riazi, A., Lamping, D. L., Fitzpatrick, R., & Thompson, A. J.
(2003). Measuring the impact of MS on walking ability: The 12‐Item
MS Walking Scale (MSWS‐12). Neurology, 60(1), 31–36. https://doi.
org/10.1212/WNL.60.1.31
Hogan, N., & Coote, S. (2013). Therapeutic interventions in the treatment
of people with multiple sclerosis with mobility problems: A literature
review. Physical Therapy Review, 14(3), 160–168. https://doi.org/
10.1179/174328809x435286
Huisinga, J. M., St George, R. J., Spain, R., Overs, S., & Horak, F. B. (2014).
Postural response latencies are related to balance control during stand-
ing and walking in patients with multiple sclerosis. Archives of Physical
Medicine and Rehabilitation, 95(7), 1390–1397. https://doi.org/
10.1016/j.apmr.2014.01.004
Humphreys, I., Drummond, A. E., Phillips, C., & Lincoln, N. B. (2013). Cost‐
effectiveness of an adjustment group for people with multiple sclerosis
and low mood: A randomized trial. Clinical Rehabilitation, 27, 963–971.
https://doi.org/10.1177/0269215513488608
Kalron, A., Feys, P., Dalgas, U., Smedal, T., Freeman, J., Romberg, A., …
Baert, I. (2019). Searching for the “Active Ingredients” in physical
rehabilitation programs across Europe, necessary to improve mobility
in people with multiple sclerosis: A multicenter study.
Neurorehabilitation and Neural Repair, 33(4), 260–270. https://doi.org/
10.1177/1545968319834893
Kalron, A., & Givon, U. (2016). Gait characteristics according to pyramidal,
sensory and cerebellar EDSS subcategories in people with multiple
sclerosis. Official Journal of the European Neurological Society, 263,
1796–1801. https://doi.org/10.1007/s00415‐016‐8200‐6
Kalron, A., Rosenblum, U., Frid, L., & Achiron, A. (2017). Pilates exercise train-
ing vs. physical therapy for improving walking and balance in people with
multiple sclerosis: A randomized controlled trial. Clinical Rehabilitation,
31(3), 319–328. https://doi.org/10.1177/0269215516637202
Kibler, W. B., Press, J., & Sciascia, A. (2006). The role of core stability in
athletic function. Sports Medicine, 36(3), 189–198. https://doi.org/
10.2165/00007256‐200636030‐00001
Kieseier, B. C., & Pozzilli, C. (2012). Assessing walking disability in multiple
sclerosis. Multiple Sclerosis Journal, 18(7), 914–924. https://doi.org/
10.1177/1352458512444498
Kjølhede, T., Vissing, K., & Dalgas, U. (2012). Multiple sclerosis and progres-
sive resistance training: A systematic review. Multiple Sclerosis Journal,
18(9), 1215–1228. https://doi.org/10.1177/1352458512437418
Krishnan, V., Kanekar, N., & Aruin, A. S. (2012a). Anticipatory postural
adjustments in individuals with multiple sclerosis. Neuroscience Letters,
506, 256–260. https://doi.org/10.1016/j.neulet.2011.11.018
Krishnan, V., Kanekar, N., & Aruin, A. S. (2012b). Feedforward postural con-
trol in individuals with multiple sclerosis during load release. Gait &
Posture, 36, 225–230. https://doi.org/10.1016/j.gaitpost.2012.02.022
Langeskov‐Christensen, D., Feys, P., Baert, I., Riemenschneider, M.,
Stenager, E., & Dalgas, U. (2017). Performed and perceived walking
ability in relation to the Expanded Disability Status Scale in persons
with multiple sclerosis. Journal of the Neurological Sciences, 382,
131–136. https://doi.org/10.1016/j.jns.2017.09.049
Learmonth, Y. C., Dlugonski, D. D., Pilutti, L. A., Sandroff, B. M., & Motl, R.
W. (2013). The reliability, precision and clinically meaningful change of
walking assessments in multiple sclerosis. Multiple Sclerosis Journal,
19(13), 1784–1791. https://doi.org/10.1177/1352458513483890
Learmonth, Y. C., & Motl, R. W. (2016). Physical activity and exercise train-
ing in multiple sclerosis: A review and content analysis of qualitative
research identifying perceived determinants and consequences. Dis-
ability and Rehabilitation, 38(13), 1227–1242. https://doi.org/
10.3109/09638288.2015.1077397Lederman, E. (2010). The myth of core stability. Journal of Bodywork
and Movement Therapies, 14(1), 84–98. https://doi.org/10.1016/j.
jbmt.2009.08.001
Lord, S. E., Halligan, P. W., & Wade, D. T. (1998). Visual gait analysis: The
development of a clinical assessment and scale. Clinical Rehabilitation,
12(2), 107–119. https://doi.org/10.1191/026921598666182531
Mehta, L., McNeill, M., Hobart, J., Wyrwich, K. W., Poon, J.‐L., Auguste,
P., … Elkins, J. (2015). Identifying an important change estimate for
the Multiple Sclerosis Walking Scale‐12 (MSWS‐12v1) for interpreting
clinical trial results. Multiple Sclerosis Journal – Experimental, Transla-
tional and Clinical, 1. https://doi.org/10.1177/2055217315596993
Motl, R. W., Sandroff, B. M., Kwakkel, G., Dalgas, U., Feinstein, A., Heesen,
C., … Thompson, A. J. (2017). Exercise in patients with multiple sclero-
sis. The Lancet Neurology, 16(10), 848–856. https://doi.org/10.1016/
S1474‐4422(17)30281‐8
Nilsagard, Y., Denison, E., Gunnarsson, L. G., & Bostrom, K. (2009). Factors
perceived as being related to accidental falls by persons with multiple
sclerosis. Disability and Rehabilitation, 31, 1301–1310. https://doi.
org/10.1080/09638280802532639
Normann, B. (2018). Facilitation of movement: New perspectives provide
expanded insights to guide clinical practice. Physiotherapy Theory and
Practice, 1–10. https://doi.org/10.1080/09593985.2018.1493165
Normann, B., Salvesen, R., & Arntzen, E. C. (2016). Group‐based individual-
ized core stability and balance training in ambulant people with
multiple sclerosis: A pilot feasibility test–retest study. European
Journal of Physiotherapy, 18(3), 173–178. https://doi.org/10.3109/
21679169.2016.1170204
Normann, B., Zanaboni, P., Arntzen, E. C., & Øberg, G. K. (2016). Innovative
physiotherapy and continuity of care in people with multiple sclerosis:
A randomized controlled trial and a qualitative study. Journal of Clinical
Trials, 06, 282. https://doi.org/10.4172/2167‐0870.1000282
Paltamaa, J., West, H., Sarasoja, T., Wikstrom, J., & Malkia, E. (2005). Reli-
ability of physical functioning measures in ambulatory subjects with
MS. Physiotherapy Research International, 10(2), 93–109. https://doi.
org/10.1002/pri.30
Pearson, M., Dieberg, G., & Smart, N. (2015). Exercise as a therapy for
improvement of walking ability in adults with multiple sclerosis: A
meta‐analysis. Archives of Physical Medicine and Rehabilitation, 96(7),
1339–1348.e1337). https://doi.org/10.1016/j.apmr.2015.02.011
Pilutti, L. A., Dlugonski, D., Sandroff, B. M., Suh, Y., Pula, J. H., Sosnoff, J. J.,
& Motl, R. W. (2013). Further validation of Multiple Sclerosis Walking
Scale‐12 scores based on spatiotemporal gait parameters. Archives of
Physical Medicine and Rehabilitation, 94, 575–578. https://doi.org/
10.1016/j.apmr.2012.08.214
Plow, M. A., Mathiowetz, V., & Lowe, D. A. (2009). Comparing individual-
ized rehabilitation to a group wellness intervention for persons with
multiple sclerosis. American Journal of Health Promotion, 24(1), 23–26.
https://doi.org/10.4278/ajhp.071211128
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi,
M., … Wolinsky, J. S. (2011). Diagnostic criteria for multiple sclerosis:
2010 revisions to the McDonald criteria. Annals of Neurology, 69,
292–302. https://doi.org/10.1002/ana.22366
Rehabilitation in Multiple Sclerosis (RIMS). (2012). European multiple scle-
rosis platform [EMSP] recommendations on rehabilitation services for
persons with multiple sclerosis in Europe. Retrieved from https://
www.eurims.org/News/recommendations‐on‐rehabilitation‐services‐
for‐persons‐with‐multiple‐sclerosis‐in‐europe.html
Rossier, P., & Wade, D. T. (2001). Validity and reliability comparison of 4
mobility measures in patients presenting with neurologic impairment.
Archives of Physical Medicine and Rehabilitation, 82(1), 9–13. https://
doi.org/10.1053/apmr.2001.9396
14 of 14 ARNTZEN ET AL.Selman, J. P., de Camargo, A. A., Santos, J., Lanza, F. C., & Dal Corso, S.
(2014). Reference equation for the 2‐minute walk test in adults and
the elderly. Respiratory Care, 59, 525–530. https://doi.org/10.4187/
respcare.02649
Shumway‐Cook, A., & Woollacott, M. H. (2017). Motor control: Translating
research into clinical practice (5th ed.). Philadelphia: Wolters Kluwer.
Snook, E. M., & Motl, R. W. (2009). Effect of exercise training on walking
mobility in multiple sclerosis: A meta‐analysis. Neurorehabilitation and
Neural Repair, 23(2), 108–116. https://doi.org/10.1177/
1545968308320641
Sosnoff, J. J., Sandroff, B. M., & Motl, R. W. (2012). Quantifying gait
abnormalities in persons with multiple sclerosis with minimal disability.
Gait & Posture, 36(1), 154–156. https://doi.org/10.1016/j.
gaitpost.2011.11.027
Twisk, J. W. R. (2013). Applied longitudinal data analysis for epidemiology: A
practical guide (2nd ed.). Cambridge: Cambridge University Press.
https://doi.org/10.1017/CBO9781139342834
Vaughan‐Graham, J., & Cott, C. (2016). Defining a Bobath clinical frame-
work—A modified e‐Delphi study. Physiotherapy Theory Practice, 32,
612–627. https://doi.org/10.1080/09593985.2016.1228722
Vickers, A. J., & Altman, D. G. (2001). Statistics notes: Analysing controlled
trials with baseline and follow up measurements. BMJ, 323,
1123–1124. https://doi.org/10.1136/bmj.323.7321.1123
Wajda, D. A., & Sosnoff, J. J. (2015). Cognitive–motor interference in
multiple sclerosis: A systematic review of evidence, correlates, and
consequences. Biomedical Research International, 720856, 1–8.
https://doi.org/10.1155/2015/720856Weikert, M., Motl, R. W., Suh, Y., McAuley, E., & Wynn, D. (2010).
Accelerometry in persons with multiple sclerosis: Measurement of
physical activity or walking mobility? Journal of the Neurological
Sciences, 290(1), 6–11. https://doi.org/10.1016/j.jns.2009.12.021
Wells, C., Kolt, G. S., & Bialocerkowski, A. (2012). Defining Pilates exercise:
A systematic review. Complementary Therapies in Medicine, 20,
253–262. https://doi.org/10.1016/j.ctim.2012.02.005
Zwarenstein, M., Treweek, S., Gagnier, J. J., Altman, D. G., Tunis, S.,
Haynes, B., … Pragmatic Trials in Healthcare Group (2008). Improving
the reporting of pragmatic trials: An extension of the CONSORT state-
ment. BMJ, 337, a2390. https://doi.org/10.1136/bmj.a2390
Zwarenstein, M., Treweek, S., & Loudon, K. (2017). PRECIS‐2 helps
researchers design more applicable RCTs while CONSORT extension
for pragmatic trials helps knowledge users decide whether to apply
them. Journal of Clinical Epidemiology, 84, 27–29. https://doi.org/
10.1016/j.jclinepi.2016.10.010
How to cite this article: Arntzen EC, Straume B, Odeh F, Feys
P, Normann B. Group‐based, individualized, comprehensive
core stability and balance intervention provides immediate
and long‐term improvements in walking in individuals with
multiple sclerosis: A randomized controlled trial. Physiother
Res Int. 2019;e1798. https://doi.org/10.1002/pri.1798
